Clinical Trial Update: MSC for Treatment of CMV Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating mesenchymal stem cells to treat cytomegalovirus infection in hematopoietic stem cell transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Mesenchymal Stem Cells (MSC) (mesenchymal stem cells)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Stem Cell Transplantation, Hematopoietic, CMV Infection | Phase 2 | Status: UNKNOWN